InvestorsHub Logo

jesster64

03/06/24 12:22 PM

#676682 RE: Nemesis18 #676681

What part of its being used allready in compassionate care cases dont you understand? forget it, on ignore buh bye

learningcurve2020

03/06/24 12:27 PM

#676686 RE: Nemesis18 #676681

Nem, Please provide more detail on this alleged situation. Thanks.

You wrote:

"No, I was 'selected' without my informed consent, due to my favourable presentations and overall genomic profile."

CrashOverride

03/06/24 1:25 PM

#676712 RE: Nemesis18 #676681

⚠️ Adam Feuerstein alert! ⚠️

dennisdave

03/07/24 9:18 AM

#676958 RE: Nemesis18 #676681

So NWBIO wants Marketing Approval for a treatment that is still being innovated & developed, with the broader paying public acting as defacto clinical trial patients !

Sure, the MHRA will go for that!

Every novel new treatment innovates, there is nothing secretive or strange about that.
And no the approval is being requested on a 10-year trial, the production method however is being innovative as is permitted by the RA as long as the drug itself is exactly as was used during the trial under approval.